Clinical Trial Update: Double Blind Trial in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

A Phase 2 double-blind clinical trial in children with Autism Spectrum Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Paxmedica

Snippet

Sponsor: Paxmedica | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED